Perkins Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Perkins Capital Management’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.16M	Sell	224,107 -5,482	-2%	-$39.7K	1.4%	23
2019 Q4	$1.15M	Sell	229,589 -6,450	-3%	-$41.7K	1.03%	32
2019 Q3	$1.88M	Buy	236,039 +43,314	+22%	+$338K	1.62%	17
2019 Q2	$1.4M	Buy	192,725 +500	+0.3%	+$3.66K	0.98%	31
2019 Q1	$1.54M	Buy	192,225 +89,125	+86%	+$838K	1.01%	31
2018 Q4	$825K	Buy	103,100 +39,300	+62%	+$471K	0.64%	49
2018 Q3	$983K	Buy	+63,800	New	+$769K	0.59%	55

Other funds holding IDXG

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allworth Financial Folsom, California $24.6B AUM 15.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Victory Capital Management

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return